National Covid-19 Immunisation Programme
Total Page:16
File Type:pdf, Size:1020Kb
NATIONAL COVID-19 IMMUNISATION PROGRAMME THE SPECIAL COMMITTEE FOR ENSURING ACCESS 18 FEBRUARY 2021 TO COVID-19 VACCINE SUPPLY (JKJAV) NATIONAL COVID-19 IMMUNISATION PROGRAMME National COVID-19 Immunisation Programme, 18 February 2021 © The Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) 2021 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written authorisation of the copyright owner. This document has been drawn up based on available information deemed accurate as of 18 February 2021. This document provides up-to-date information on the Immunisation Programme policies, vaccine supply procurement strategies as well as the implementation of COVID-19 vaccination effort and monitoring to curb the COVID-19 pandemic in Malaysia. The information in this document will be updated from time to time based on latest developments and information. Published by: THE SECRETARIAT OF THE SPECIAL COMMITTEE FOR ENSURING ACCESS TO COVID-19 VACCINE SUPPLY (JKJAV) Facebook Messenger Link: m.me/jkjavmy Data analysis, content curation and writing services provided by the Academy of Sciences Malaysia “The Government’s strategy is to ensure as many residents in Malaysia as possible will receive the vaccine to save lives in the fastest possible time. The vaccine will be provided for free to all citizens and non-citizens of Malaysia. Once the vaccine rollout is completed, the hope is that our national economy will be able to recover and the lives of the rakyat will improve. However, we must still take precautionary steps to ensure that the pandemic does not reoccur.“ YAB Tan Sri Muhyiddin Yassin Prime Minister of Malaysia 4 “The document outlines the national strategic plan to ensure the National COVID-19 Immunisation Programme runs smoothly, safely, effectively and in an orderly manner in the effort to curb and end the COVID-19 pandemic in Malaysia. A whole-of-Government and whole-of-society approach has been adopted, which involves numerous Ministries and Government Agencies, State Governments, Non-Governmental Organisations (NGOs), the private sector and members of the community to ensure the programme achieves its target.“ YB Dato’ Sri Dr Adham Baba YB Khairy Jamaluddin Minister of Health Malaysia Minister of Science, Technology and Innovation Co-chairs of the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) 5 Vaccines are one of the methods for us to The Special Committee for Ensuring curb this pandemic and one of the best Access to COVID-19 Vaccine Supply ways to protect our society from COVID-19. (JKJAV) which is co-chaired by the Since the beginning of the pandemic, Minister of Health Malaysia and the various efforts have been carried out Minister of Science, Technology and globally to develop COVID-19 vaccines. Innovation, was established to ensure timely access to the supply of COVID-19 vaccines for the country. Want to know about vaccines? What is a vaccine? What is the importance & the How was the COVID-19 Vaccines contain antigens that use of vaccines in Malaysia? vaccine able to be developed serve to stimulate the body’s Since the early 1950s, vaccines so quickly? immune system and form have been given out through Shortly after the virus genetic immunity for specific infectious the National Immunisation code was shared by researchers diseases. Programme to protect Malaysian from China in January 2020, citizens from vaccine-preventable vaccine development efforts What is a COVID-19 vaccine? diseases. took place intensively at the global level. For the first time, The COVID-19 vaccine stimulates To date, 11 types of vaccines to the development of vaccines the immune system so that in the prevent 13 types of vaccine- was accelerated through major instance of exposure to SARS- preventable diseases have global investment by various CoV-2 (severe acute respiratory been given to children – which parties such as countries, syndrome coronavirus 2), our are Tuberculosis, Hepatitis B, world bodies, pharmaceutical body would be able to react Diphtheria, Tetanus, Whooping companies and individuals. against the COVID-19 infection. Cough (Pertussis), Polio, The rapid development of the Various platforms such as RNA Haemophilus Influenza Type B vaccines is also the result of genetic sequencing, viral vectors, (Hib), Measles, Rubella, Mumps, previous studies on pathogens deactivating viruses and protein Pneumococcal, Japanese that have triggered pandemics, sub-units have been used to Enchepalitis (JE) and Human epidemics and endemics such develop safe and effective Papillomavirus (HPV). as the Nipah Virus, Severe Acute coronavirus vaccines. It gives Additionally, the meningococcal Respiratory Syndrome (SARS) you the best protection against vaccine is also compulsory for all and Middle East Respiratory COVID-19. Malaysians heading to perform Syndrome (MERS). their hajj and umrah. Source: Ministry of Health (MOH) Source: MOH Source: JKJAV 6 JKJAV also plays an important role as This document aims to serve as a the primary committee in the planning, reference point for information and implementation and monitoring of the as a general guide for implementers entire National COVID-19 Immunisation (at the state and agency levels and Programme. The National COVID-19 the community on vaccines, the Immunisation Programme outlines the implementation process as well as policies, vaccine supply procurement security and monitoring efforts that strategies, implementation efforts will be carried out by the Government. and monitoring to curb the COVID-19 pandemic nationally. COVID-19 marks a new What is the fatwa for Has the COVID-19 vaccine history in clinical trials COVID-19 vaccination? fulfilled all the criteria of the Clinical trials are important to The Special Muzakarah relevant laws? test the effectiveness and safety (discussion) of National Council Yes, it has. The COVID-19 vaccine of newly developed vaccines. for the Islamic Religious Affairs is regulated and complies with COVID-19 has made history in (MKI) had decided that the the following Acts: the medical field as it involved use of the COVID-19 vaccine is • Poisons Act 1952 (Act 366) and 10 times the usual number of permissible (harus). volunteers compared to other its regulations vaccines because it was easy to The use of vaccines to protect • Sale of Drugs Act 1952 (Act 368) get volunteers as a result of the mankind from dangerous and its regulations fact that the COVID-19 pandemic diseases is unusual in Islam but was happening concurrently has been in practice since 1988. • Drugs and Cosmetic Control globally and has posed a global Besides Malaysia, other world Regulations 1984 threat. fatwa institutions have also decreed the need for vaccine • Infectious Disease Prevention use, among them are the leading and Control Act (Act 342) Source: FAQ MOH & MOSTI institutions of al-Azhar al-Sharif; Fatwa Council of the United Source: MOH Arab Emirates Government; and Majma ‘Fuqaha’ al-Shari’ah United States. Source: Department of Islamic Development Malaysia 7 Timeline for Malaysia’s Vaccine vaccine acquisition Supply Fill and finish term sheet agreements signed with Malaysian vaccine FEB manufacturers Malaysia receives 2022 The Public Accounts the first vaccine Committee was satisfied with the COVID-19 national vaccine procurement strategy Implementation of the FEB National COVID-19 2021 Immunisation Programme 5 JAN Dec 2020 - Now 2021 Evaluation & conditional approval by the National Pharmaceutical Regulatory Division (NPRA) & Drug Control Authority (DCA). Pfizer has obtained conditional approval DEC 2020 14 OCT Prime Minister 2020 announced that Malaysia has gained APR access to vaccines for The establishment 82.8% population of of the Special 2020 Malaysia Committee for Ensuring Access to Covid-19 Vaccine • Science diplomacy JAN Supply (JKJAV) approach was 2020 Bilateral Negotiations mobilised by • Countries that develop vaccines MOH-MOSTI-MFA (China, USA, Russia, United Kingdom etc.) • Science diplomacy • China distributed the • 12 companies that manufacture vaccines was carried out with genetic code for COVID-19 countries & vaccine • Vaccine development Multilateral Negotiations manufacturers as commences globally • COVID-19 Vaccine Facility Global Access well as global (COVAX) alliances and bodies • Coalition for Epidemic Preparedness for immunisation & Innovation (CEPI) health DEC 2019 COVID-19 Source: JKJAV is detected Analysis & compilation: ASM 8 Strategies for the Access and Acquisition of the COVID-19 vaccine The need to get supplies of safe and efficacious vaccine is a national priority to ensure that the National COVID-19 Immunisation Programme can be implemented to curb this pandemic. The Government has taken an integrated and structured approach in its vaccine acquisition effort for the country by leveraging on its diplomatic relations and strategic international cooperation with countries, vaccine manufacturers as well as world health bodies and affiliates. Through science diplomacy efforts that were jointly carried out by the Ministry of Health (MOH), Ministry of Foreign Affairs (MFA) and the Ministry of Science, Technology and Innovation (MOSTI) starting April 2020, the Government has adopted a multi-pronged approach to enable Malaysia to secure access to a portfolio of COVID-19 vaccines which is being actively developed worldwide. The strategic international cooperation,